Multimarker risk strategy for predicting 1-month and 1-year major events in non–ST-elevation acute coronary syndromes - 21/08/11
, Juan Sanchis, MD, FESC, Àngel Llàcer, MD, Lorenzo Fácila, MD, Julio Núñez, MD, Mauricio Pellicer, MD, Vicente Bertomeu, MD, Vicente Ruiz, MD, Francisco J. Chorro, MD, FESC
Reprint requests: Vicent Bodí MD, Servei de Cardiología, Hospital Clínic i Universitari, Avda Blasco Ibáñez 17, 46010 València, Spain.This work was supported by a grant from RECAVA-FICS.
Résumé |
Background |
The aim of this study was to define the utility of the combined measurement of troponin I, myoglobin, C-reactive protein, fibrinogen, and homocysteine to predict risk in non–ST elevation acute coronary syndromes.
Methods |
Troponin I, myoglobin, high-sensitivity C-reactive protein, fibrinogen, and homocysteine were measured in 557 consecutive patients admitted to our institution for non–ST elevation acute coronary syndrome. The risk for major events (death or nonfatal myocardial infarction) at first month and at first year follow-up was analyzed.
Results |
In a multivariate model adjusting for baseline characteristics and electrocardiographic changes, the only biomarkers related to major events at first month were C-reactive protein (P = .007) and myoglobin (P = .02), and at first year troponin I (P = .02), C-reactive protein (P = .03), and homocysteine (P = .04). The rate of major events depending on the number (0-5) of elevated biomarkers were at first month: 4.1%, 3.7%, 5.7%, 6.1%, 6.5%, and 30.8% (P < .0001), and at first year: 8.2%, 11.1%, 12.3%, 16.2%, 23.7%, and 50% (P < .0001). A simple score including the number of elevated biomarkers showed an adjusted risk of major events of 1.6 [1.3-1.9] at first month and of 1.4 [1.2-1.7] at first year.
Conclusions |
Markers of myocardial damage, inflammation, and homocysteine analyzed separately provide prognostic information. The number of elevated biomarkers is an independent risk predictor of major events.
Le texte complet de cet article est disponible en PDF.Plan
Vol 149 - N° 2
P. 268-274 - février 2005 Retour au numéro
Article précédent
- Correction
- Antonio Cittadini
- Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non–ST-elevation acute coronary syndromes: Observations from the OPUS-TIMI 16 trial
- Warren J. Cantor, Shaun G. Goodman, Christopher P. Cannon, Sabina A. Murphy, Andrew Charlesworth, Eugene Braunwauld, Anatoly Langer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?